Skip to content

OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?

OSA-18 in Children With Mild Obstructive Sleep Apnea: Can it be a Helpful Decision Making Tool?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05911646
Acronym
OSA-18
Enrollment
130
Registered
2023-06-22
Start date
2021-06-02
Completion date
2027-05-31
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea, Obstructive Sleep, Obstructive Sleep Apnea

Keywords

Mild Obstructive Sleep Apnea

Brief summary

The concept is a novel research idea that incorporates the potential impact of patient quality of life (QOL) on decision-making for treatment of mild obstructive sleep apnea (OSA). Our hypothesis is that in children with mild OSA there is significant conflict with parental decision-making; in the absence of significant sleep apnea, there is limited research regarding comparative efficacy of various treatment options. The impact of a QOL questionnaire can be a significant deciding factor and may help guide management decisions in such situations.

Detailed description

This concept is a novel research idea that incorporates the potential impact of patient quality of life (QOL) on decision making for treatment of mild sleep apnea in children between the ages of 3yrs to \<16 years. Previous studies have shown that parents of children with mild OSA experience similar decisional conflict (DC) to those with a more severe disease. The investigators believe it is important to provide caregivers with tools that can aid in decision making and potentially reduce DC when choosing between more than one treatment option, considering research on some of these options is also recent and somewhat limited. Children with mild OSA may be offered watchful waiting, surgery or medical therapy for initial management. Although surgery results in resolution/improvement in symptoms in the majority of children with mild OSA, recent data also shows encouraging success rates after medical management. A well-designed RCT has also shown that untreated children with non-severe OSA show normalization of PSG with watchful waiting, although they continued to have higher OSA18 scores as compared to those who underwent surgery. This implies that there is a continuing impact on quality of life and warrants inclusion of this information early on in the decision-making process. When presented with these data, some parents face a conflict deciding between management options and/or may be reluctant to pursue the recommended management option. This is known as "decisional conflict" and is frequently accompanied by emotional distress, which can lead to delays in decision making. The hypothesis is that in children with mild OSA there is significant conflict in parental decision making, and, in the absence of significant sleep apnea, impact on QOL can be a statistically significant deciding factor and may help guide management decisions in such situations. Investigators propose to use OSA 18, a validated questionnaire that determines the effects of obstructive sleep apnea on pediatric quality of life, and subsequently measure caregivers' decision-making processes through a decisional conflict scale survey. Investigators believe that using this questionnaire may impact decision making for such patients and help reduce the DC. This will be a randomized controlled trial (RCT). Identification and Recruitment: Convenience sampling will be used for this study. The clinic lists will be scanned weekly by a member of the study team to identify patients with mild OSA. Consecutive patients/ families, meeting inclusion criteria will be invited to participate. Participants will be approached by a member of the study team on the day of visit or within 1 week of the visit by a telephone call to enlist participation. Consent/Assent: Verbal consent will be obtained through the phone call and confirmed on the day of clinic visit and documented in the consent documentation form which will be locked away in a secure cabinet and also documented on the network drive. A secure REDCap database will also be used to document verbal consent in the instance that recruitment was done telephonically. Verbal consent will be obtained at the time of recruitment by a study team member. The team member will introduce the study and explain the purpose, the procedures, and how participants are randomly assigned to a group. Retention: Participation last through the completion of all surveys. The surveys take approximately 5 minutes to complete. Protocol: At the start of the visit, families who consented to participate will be given a demographics questionnaire asking about age, race/ethnicity, and health literacy. BMI and sleep study data will also be recorded by a study team member. Following this survey, participants will follow the protocol for the group they are randomly assigned to, either case or control. Case Group: If in case group, parents will be asked to complete the OSA18 questionnaire. The total score along with category: mild, moderate or severe will be presented to the families along with scores for various domains. Families will then be provided with a printed form, "decision aid," at the time of consultation with various management options, detailing evidence based risks and benefits for each option. In the case group, this will include the OSA 18 total scores at the bottom this will also help standardized the discussion by the provider. The decisional conflict scale (DCS) will be filled out at conclusion of visit after the provider has left the room. The DCS is a 16-item survey in which participants are asked to respond to statements related to their decision on a five-point ordinal Likert scale: 0) strongly agree, 1) agree, 2) neither agree nor disagree, 3) disagree, and 4) strongly disagree. Scores are summed, divided by16, and multiplied by 25. Scores range from 0, signifying that the respondent has complete certainty about the best choice, to 100, which signifies that the respondent feels extremely uncertain about the best choice. The validation study indicates that a score ≥ 25 signifies a decisional conflict. Control Group: Families in the control group will be provided with a printed form, "decision aid," at the time of consultation with various management options, detailing evidence based risks and benefits for each option. The decisional conflict scale (DCS) will be filled out at conclusion of visit after the provider has left the room. The DCS is a 16-item survey in which participants are asked to respond to statements related to their decision on a five-point ordinal Likert scale: 0) strongly agree, 1) agree, 2) neither agree nor disagree, 3) disagree, and 4) strongly disagree. Scores are summed, divided by16, and multiplied by 25. Scores range from 0, signifying that the respondent has complete certainty about the best choice, to 100, which signifies that the respondent feels extremely uncertain about the best choice. The validation study indicates that a score ≥ 25 signifies a decisional conflict. Responses from all participants will be stored securely in a de-identifiable manner.

Interventions

OTHEROSA-18 Survey

OSA 18 is an 18-item questionnaire that uses a Likert-type scoring system to collect information about 5 subscales that are considered to be elements in quality of life: sleep disturbance, physical symptoms, emotional symptoms, daytime function, and caregiver concerns. On the basis of this information, a summary score is calculated and scores are divided into three categories: Mild (40-60), moderate (61-80) and severe \>81.

OTHERDecisional Conflict (DCS)

The DCS is a 16-item survey in which participants are asked to respond to statements related to their decision on a five-point ordinal Likert scale: 0) strongly agree, 1) agree, 2) neither agree nor disagree, 3) disagree, and 4) strongly disagree. Scores are summed, divided by 16, and multiplied by 25. Scores range from 0, signifying that the respondent has complete certainty about the best choice, to 100, which signifies that the respondent feels extremely uncertain about the best choice.

Sponsors

Connecticut Children's Medical Center
Lead SponsorOTHER
ResMed Foundation
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

A simple, fixed randomization will be performed using an excel spreadsheet. A randomization formula will be used to assign each new participant a number 1 or 2. All individuals assigned the number "1" will be designated as control and all individuals assigned the number "2" will be designated as case. The randomization will continue until 65 participants is reached for one group. At that time, any new recruited patients will be automatically assigned either control or case, depending on which group has not reached 65 participants. The randomization will be done at the time of consenting.

Eligibility

Sex/Gender
ALL
Age
3 Years to 12 Years
Healthy volunteers
Yes

Inclusion criteria

* Parent/caregiver of child with an initial diagnosis mild obstructive sleep apnea defined as polysomnography AHI score between 1 and 5 * Parent/caregiver of child between 3 and 12 years of age * Parent/caregiver of child who has been diagnosed with tonsillar hypertrophy grade 2 or higher

Exclusion criteria

* Parent/caregiver of child diagnosed with a syndromic or known neurologic condition and/or multiple (more than two) medical cardiac or respiratory medical conditions * Parent/caregiver of child who has previously underwent tonsillectomy

Design outcomes

Primary

MeasureTime frameDescription
Decisional Conflict Scale (DCS)Through clinical visit, an average of 30 minutesThe Decisional Conflict Scale (DCS) is a survey administered to both the experimental and active comparator evaluating the degree of conflict a caregiver feels when determining a treatment option. The minimum score is 0 (indicating no decisional conflict) and the maximum score is 100 (indicating significant decisional conflict).

Secondary

MeasureTime frameDescription
Gender of child and parent/legal guardianThrough clinical visit, an average of 30 minutes* Male * Female * Intersex * None of these describe my child * Prefer not to answer
Age of child and parent/legal guardianThrough clinical visit, an average of 30 minutesyears
Race/Ethnicity of child and parent/legal guardianThrough clinical visit, an average of 30 minutes* American Indian or Alaska Native * Asian * Black or African American * Hispanic or Latino * Native Hawaiian or Other Pacific Islander * White * Prefer not to answer
Parent/legal guardian identified health care literacy and comfort completing medical forms.Through clinical visit, an average of 30 minutes* Extremely * Quite a bit * Somewhat * A little bit * Not at all
BMI percentileThrough clinical visit, an average of 30 minutesBMI reported as kg/m\^2 will be reported as a percent based on the growth chart.
BMI Z-scoreThrough clinical visit, an average of 30 minutesnumber value of BMI z-score
Polysomnography (PSG) (Sleep Study Data), AHIThrough study completion, and average of 3 monthsApnea Hypopnea Index (AHI) will be recorded from the PSG. Value is reported as a real number.
Polysomnography (PSG) (Sleep Study Data), OAHIThrough study completion, and average of 3 monthsObstructive apnea hypopnea index (OAHI) will be recorded from the PSG. Values is reported as a real number.
Polysomnography (PSG) (Sleep Study Data), high CO2 occurrencesThrough study completion, and average of 3 monthsThe number of times the patient has a CO2 level of \>50mmHG during the course of the sleep study will be recorded.
Polysomnography (PSG) (Sleep Study Data), minimum oxygen saturationThrough study completion, and average of 3 monthsThe lowest oxygen saturation of the patient during the sleep study, sometimes called nadir O2, will be recorded.
Selected Treatment OptionThrough clinical visit, an average of 30 minutesParent/Caregiver will choose between surgery, medication, watchful waiting, or undecided at their regularly scheduled clinical visit.

Countries

United States

Contacts

CONTACTNancy Grover, MD
ngrover@connecticutchildrens.org860- 545- 9650
CONTACTCameron King, MA
CKing02@connecticutchildrens.org8608375595
PRINCIPAL_INVESTIGATORNancy Grover, MD

Connecticut Children's Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026